Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07086209

Optimizing Hamstring Rehabilitation With Amino Acids

Optimizing Hamstring Rehabilitation With Amino Acids: A Randomized Controlled Study for Seamless Return to Sports in Football Athletes

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Universidad de Zaragoza · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

Hamstring injuries are among the most prevalent and troublesome injuries in athletes, particularly those engaged in sports that require high-speed movements such as sprinting, kicking, and rapid changes in direction. The hamstring muscles, which include the biceps femoris, semitendinosus, and semimembranosus, are essential for powerful lower limb actions, and thus, any injury to these muscles can significantly impact an athlete's performance and recovery. These injuries often occur during eccentric muscle contractions, such as when the muscles lengthen rapidly under tension, as seen in running and sprinting. According to epidemiological studies, hamstring strains account for a substantial portion of sports-related injuries, with hamstring strains being the most commonly reported injury in disciplines such as football, soccer, rugby, and athletics. In professional football, for instance, hamstring injuries account for approximately 12% of all injuries and represent the most frequent muscle strain, underlining their significance in the context of athletic performance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBranched-Chain Amino Acid SupplementOral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.
BEHAVIORALTherapeutic Exercise Program6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.

Timeline

Start date
2025-09-19
Primary completion
2025-10-19
Completion
2025-10-20
First posted
2025-07-25
Last updated
2025-07-25

Source: ClinicalTrials.gov record NCT07086209. Inclusion in this directory is not an endorsement.